12:00 AM
Dec 19, 2011
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Zealand Pharma completes warrant exercise

Zealand Pharma A/S (CSE:ZEAL), Glostrup, Denmark
Business: Endocrine/Metabolic, Cardiovascular, Gastrointestinal

Read the full 34 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >